Gain Therapeutics Inc. (GANX)

1.96

-0.17 (-7.98%)

At close: Mar 03, 2025, 3:59 PM

1.92

-2.05%

After-hours: Mar 03, 2025, 04:04 PM EST

Gain Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Net Income	-22.27M	-17.59M	-13.89M	-3.58M	-2.19M	-1.11M
Depreciation & Amortization	83.58K	64.17K	15.48K	9.59K	2.57K	741.00
Stock-Based Compensation	3.26M	1.53M	839.37K	81.64K	n/a	n/a
Other Working Capital	1.09M	448.15K	34.7K	-129.31K	218.99K	201.55K
Other Non-Cash Items	-383.19K	-206.86K	-34.13K	8.71K	10.1K	41.05K
Deferred Income Tax	n/a	n/a	1.09M	n/a	n/a	n/a
Change in Working Capital	442.23K	1.51M	-385.11K	237.5K	312.26K	319.23K
Operating Cash Flow	-18.87M	-14.69M	-12.37M	-3.24M	-1.87M	-744.51K
Capital Expenditures	-15.36K	-118.95K	-94.21K	-20.83K	-13.72K	-7.99K
Acquisitions	n/a	14.66M	n/a	n/a	n/a	n/a
Purchase of Investments	-1.96M	-17.74M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	12.19M	3.08M	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	-14.66M	n/a	n/a	n/a	7.99K
Investing Cash Flow	10.22M	-14.77M	-94.21K	-20.83K	-13.72K	-7.99K
Debt Repayment	-89.07K	-78.77K	-21.95K	738.28K	n/a	983.78K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	-841.27K	9.75M	1.75M	n/a
Financial Cash Flow	12.64M	-78.77K	41.77M	10.49M	1.75M	983.78K
Net Cash Flow	4.49M	-29.57M	29.41M	7.19M	-97.19K	237.88K
Free Cash Flow	-18.88M	-14.81M	-12.46M	-3.26M	-1.88M	-752.5K